Anna Eichinger1, Alexandra Hagen1, Melanie Meyer-Bühn1, Johannes Huebner2. 1. Division of Pediatric Infectious Disease, Dr. v. Hauner Children's Hospital, LMU Munich, University of Munich (LMU), Lindwurmstraße 4, 80337, Munich, Germany. 2. Division of Pediatric Infectious Disease, Dr. v. Hauner Children's Hospital, LMU Munich, University of Munich (LMU), Lindwurmstraße 4, 80337, Munich, Germany. johannes.huebner@med.uni-muenchen.de.
Abstract
BACKGROUND: Sepsis-like illness with suspected meningitis or encephalitis is a common reason for using empiric antimicrobial therapy in infants and children. However, in cases of viral meningitis not covered by these antimicrobials, this management is ineffective and due to side effects potentially harmful. METHODS: A retrospective analysis of cerebrospinal fluid (CSF) multiplex PCRs (Biofire FilmArray®) in children with clinical suspicion of meningitis, encephalitis or sepsis-like illness was performed over the period of 1 year. Subsequently, a subgroup of children (age of 8-84 days of life) diagnosed with viral meningitis (enterovirus, HHV-6, human parechovirus) was compared to an age-matched control group. RESULTS: During the study period, the multiplex PCR panel was performed on 187 individual CSF samples that met the inclusion criteria. About half of the patients (92/187) were less than 1 year of age. In 27 cases (14.4%), the PCR yielded a positive result with the majority (12/27) being indicative of an enteroviral infection. In the age group of 8-84 days of life, 36.4% of the patients had a positive result. When the patients with a PCR positive for a viral agent were compared to an age-matched group of patients, no differences were observed regarding symptoms and laboratory parameters. However, the duration of antimicrobial therapy could be significantly reduced through the use of multiplex PCR. CONCLUSION: The use of on-site diagnostic multiplex PCR was able to reduce the use of antimicrobials in selected cases. This test can guide clinical decisions earlier during the course of medical care compared to standard diagnostics.
BACKGROUND:Sepsis-like illness with suspected meningitis or encephalitis is a common reason for using empiric antimicrobial therapy in infants and children. However, in cases of viral meningitis not covered by these antimicrobials, this management is ineffective and due to side effects potentially harmful. METHODS: A retrospective analysis of cerebrospinal fluid (CSF) multiplex PCRs (Biofire FilmArray®) in children with clinical suspicion of meningitis, encephalitis or sepsis-like illness was performed over the period of 1 year. Subsequently, a subgroup of children (age of 8-84 days of life) diagnosed with viral meningitis (enterovirus, HHV-6, human parechovirus) was compared to an age-matched control group. RESULTS: During the study period, the multiplex PCR panel was performed on 187 individual CSF samples that met the inclusion criteria. About half of the patients (92/187) were less than 1 year of age. In 27 cases (14.4%), the PCR yielded a positive result with the majority (12/27) being indicative of an enteroviral infection. In the age group of 8-84 days of life, 36.4% of the patients had a positive result. When the patients with a PCR positive for a viral agent were compared to an age-matched group of patients, no differences were observed regarding symptoms and laboratory parameters. However, the duration of antimicrobial therapy could be significantly reduced through the use of multiplex PCR. CONCLUSION: The use of on-site diagnostic multiplex PCR was able to reduce the use of antimicrobials in selected cases. This test can guide clinical decisions earlier during the course of medical care compared to standard diagnostics.
Entities:
Keywords:
Antimicrobial stewardship; Encephalitis; FilmArray; Meningitis; Point-of-care test
Authors: Stephanie J Bissel; Roland N Auer; Cheng-Hsuan Chiang; Julia Kofler; Geoffrey H Murdoch; W Allan Nix; Michael Painter; Maxime Richer; Hervé Sartelet; Guoji Wang; Clayton A Wiley Journal: J Neuropathol Exp Neurol Date: 2015-08 Impact factor: 3.685
Authors: Enjie Zhang; Adam J Bell; Gavin S Wilkie; Nicolás M Suárez; Chiara Batini; Colin D Veal; Isaac Armendáriz-Castillo; Rita Neumann; Victoria E Cotton; Yan Huang; David J Porteous; Ruth F Jarrett; Andrew J Davison; Nicola J Royle Journal: J Virol Date: 2017-10-27 Impact factor: 5.103
Authors: Sara Radmard; Savina Reid; Prajwal Ciryam; Alexandra Boubour; Nhan Ho; Jason Zucker; Dean Sayre; William G Greendyke; Benjamin A Miko; Marcus R Pereira; Susan Whittier; Daniel A Green; Kiran T Thakur Journal: Front Neurol Date: 2019-03-26 Impact factor: 4.003
Authors: Juliana Trujillo-Gómez; Sofia Tsokani; Catalina Arango-Ferreira; Santiago Atehortúa-Muñoz; Maria José Jimenez-Villegas; Carolina Serrano-Tabares; Areti-Angeliki Veroniki; Ivan D Florez Journal: EClinicalMedicine Date: 2022-02-14
Authors: Veena Ramachandran; Stephen C Elliott; Kathie L Rogers; Randall J Cohrs; Miles Weinberger; Wallen Jackson; John E Carpenter; Charles Grose; Daniel J Bonthius Journal: J Child Neurol Date: 2020-07-17 Impact factor: 1.987